Having trouble viewing this email? View in your browser.
ESCMID Logo

12 September 2017
WEEKLY NEWS

Dear colleagues,

Remember to submit your research grant proposal related to bacterial infections & diseases (incl. diagnostics, pathogenesis, antibacterial susceptibility & resistance, antibacterial stewardship and vaccines) before 11 October 2017!

The ESCMID Conference on Vaccines came to a successful conclusion on Sunday. You can read more about it in our upcoming newsletters. Participants were interested in a World Health Organization draft protocol for clinical trials for assessing non-specific effects of vaccines, which was mentioned during the conference. This is the link to the call for public comments.

The Wellcome Trust in partnership with the U.K. and Thai governments and the UN Foundation will organize a conference in Berlin on 12 and 13 October 2017 to accelerate action on drug-resistant infections. The conference aims to support the work of the Antimicrobial Resistance Inter-Agency Coordination Group (IACG).

We encourage you to become involved at your institution on World Sepsis Day on 13 September 2017. There will be events for medical professionals and public events such as open days in hospitals and healthcare facilities.

 

Abstract submission for ECCMID 2018 in Madrid is open

Abstracts may be submitted until 30 November 2017 at 23.59 CET. The abstract topics and the abstract guidelines may be found on the website. You will also find a tutorial video to guide you through the process if you have never submitted an abstract to ECCMID.

Come and join more than 10,000 colleagues at the largest, most comprehensive and most influential meeting in the fields of clinical microbiology, infectious disease and infection control. Present and discuss your research from 21 – 24 April 2018 at ECCMID 2018 in Madrid, Spain. Registration will open on 25 September 2017.

› Read more
 

CMI highlight: review on scientific impact of Ebola epidemic

Researchers systematically reviewed publicly available information on the scientific impact of the Ebola epidemic. They conclude that the Ebola outbreak had a significant scientific impact and resulted in high impact factor numbers. The main impact could be measured in the Americas and Europe, and was directly related to funding. African researchers were only marginally involved in the scientific processing (86.6% of all researchers were not African), perhaps due to the fact that major research centres are located in America and Europe. This emphasizes the importance of promoting closer cooperation between regions.

› Read more
 

Join the TAE Steering Committee before the deadline of 18 September

The Steering Committee of the Trainee Association of ESCMID (TAE) is looking for two new members to help it continue its mission to facilitate better trans-European collaboration and effective use of resources across its ever-expanding network of young CM and ID professionals.  Among its many successes in 2017, the TAE published a paper on personal life and working conditions of trainees and young specialists in clinical microbiology and infectious diseases in Europe, held a successful TAE Day at ECCMID 2017 (picture), and launched a survey on supervision, mentorship and management.  
 
You have just one more week to nominate yourself to play a key role in the activities of TAE in the coming years. Don’t miss this rare opportunity – act before 18 September! 

› Read more
 

ESGBOR publishes position paper on Lyme borreliosis diagnosis

The ESCMID group for Lyme borreliosis, ESGBOR, published a position paper on the diagnosis of the tick-borne infection caused by Borrelia burgdorferi sensu lato. The most frequent clinical manifestations Lyme borreliosis (LB) are erythema migrans and Lyme neuroborreliosis. Currently, a large volume of diagnostic testing for Lyme borreliosis is reported, whereas the incidence of clinically relevant disease manifestations is low. This indicates overuse of diagnostic testing for LB with implications for patient care and cost effective health management. The recommendations provided in this review are intended to support both the clinical diagnosis and initiatives for a more rational use of laboratory testing in patients with clinically suspected Lyme borreliosis.

The main recommendations according to current European case definitions for Lyme borreliosis are as follows: Typical erythema migrans should be diagnosed clinically and does not require laboratory testing, the diagnosis of Lyme neuroborreliosis requires laboratory investigation of the spinal fluid including intrathecal antibody production for, and the remaining disease manifestations require testing for antibodies to Borrelia burgdorferi. Testing individuals with non-specific subjective symptoms is not recommended because of a low positive predictive value.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.